Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Feb;3(1 Suppl 1):50–55. doi: 10.1111/j.1365-2125.1976.tb03713.x

Work performance versus clinical assessment in the evaluation of phenothiazine therapy.

P Harper, C Chacon
PMCID: PMC2958722  PMID: 9959

Full text

PDF
50

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRIMER A., SCHNIEDEN H., SIMON A. THE EFFECT OF CHLORPROMAZINE AND CHLORDIAZEPOXIDE ON COGNITIVE FUNCTIONING. Br J Psychiatry. 1964 Sep;110:723–725. doi: 10.1192/bjp.110.468.723. [DOI] [PubMed] [Google Scholar]
  2. Chacon C., Harper P. Clinical and work performance variables in phenothiazine therapy of schizophrenia. Acta Psychiatr Scand. 1973;49(1):65–76. doi: 10.1111/j.1600-0447.1973.tb04399.x. [DOI] [PubMed] [Google Scholar]
  3. Chacon C., Harper P., Harvey G. F. Work study in the assessment of the effects of phenothiazines in schizophrenia. Compr Psychiatry. 1972 Nov-Dec;13(6):549–554. doi: 10.1016/0010-440x(72)90055-7. [DOI] [PubMed] [Google Scholar]
  4. Crookes T. G., Hutt S. J. Perception of hidden figures by neurotic and schizophrenic patients. Br J Psychiatry. 1970 Mar;116(532):335–336. doi: 10.1192/bjp.116.532.335. [DOI] [PubMed] [Google Scholar]
  5. ESSER A. H., CHAMBERLAIN A. S., CHAPPLE E. D., KLINE N. S. PRODUCTIVITY OF CHRONIC SCHIZOPHRENICS IN A SHELTERED WORKSHOP: A QUANTITATIVE EVALUATION OF THE EFFECTS OF DRUG THERAPY. Compr Psychiatry. 1965 Feb;6:41–50. doi: 10.1016/s0010-440x(65)80007-4. [DOI] [PubMed] [Google Scholar]
  6. Glick S. D., Goldfarb T. L., Robustelli F., Geller A., Jarvik M. E. Impairment of delayed matching in monkeys by chlorpromazine and pentobarbital. Psychopharmacologia. 1969;15(2):125–133. doi: 10.1007/BF00407045. [DOI] [PubMed] [Google Scholar]
  7. HOWELL R. J., BROWN H. M., Jr, BEAGHLER H. E. A comparison of fluphenazine, trifluoperazine and a placebo in the context of an active treatment unit. J Nerv Ment Dis. 1961 Jun;132:522–530. doi: 10.1097/00005053-196106000-00007. [DOI] [PubMed] [Google Scholar]
  8. Johnson D. A., Freeman H. Long-acting tranquillizers. Practitioner. 1972 Mar;208(245):395–400. [PubMed] [Google Scholar]
  9. Jones I. H. Drugs and motor activity in chronic schizophrenia. Br J Psychiatry. 1969 Jul;115(524):851–856. doi: 10.1192/bjp.115.524.851. [DOI] [PubMed] [Google Scholar]
  10. Kurland A. A., Richardson J. H. A comparative study of two long acting phenothiazine preparations, fluphenazine-enanthate and fluphenazine-decanoate. Psychopharmacologia. 1966;9(4):320–327. doi: 10.1007/BF00408331. [DOI] [PubMed] [Google Scholar]
  11. MACULANS G. A. COMPARISON OF DIAZEPAM, CHLORPROTHIXENE AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS. Dis Nerv Syst. 1964 Mar;25:164–168. [PubMed] [Google Scholar]
  12. Mirsky A. F., Bloch S. Effects of chlorpromazine, secobarbital and sleep deprivation on attention in monkeys. Psychopharmacologia. 1967;10(5):388–399. doi: 10.1007/BF00403979. [DOI] [PubMed] [Google Scholar]
  13. Neal C. D., Imlah N. W. Institutional management of chronic schizophrenics with fluphenazine decanoate. Dis Nerv Syst. 1970 Sep;31(Suppl):24–27. [PubMed] [Google Scholar]
  14. Rice J. K. Disordered language as related to autonomic responsivity and the process-reactive distinction. J Abnorm Psychol. 1970 Aug;76(1):50–54. doi: 10.1037/h0029658. [DOI] [PubMed] [Google Scholar]
  15. SIMPSON G. M., AMIN M., KUNZ E., MCCAFFERTY F. V. STUDIES ON A SECOND LONG-ACTING FLUPHENAZINE. Am J Psychiatry. 1965 Feb;121:784–787. doi: 10.1176/ajp.121.8.784. [DOI] [PubMed] [Google Scholar]
  16. STOTSKY B. A. Motivation and task complexity as factors in the psychomotor responses of schizophrenics. J Pers. 1957 Mar;25(3):327–343. doi: 10.1111/j.1467-6494.1957.tb01531.x. [DOI] [PubMed] [Google Scholar]
  17. Shakow D. Psychological deficit in schizophrenia. Behav Sci. 1963 Oct;8(4):275–305. doi: 10.1002/bs.3830080402. [DOI] [PubMed] [Google Scholar]
  18. Simpson G. M., Angus J. W. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11–19. doi: 10.1111/j.1600-0447.1970.tb02066.x. [DOI] [PubMed] [Google Scholar]
  19. WADSWORTH W. V., WELLS B. W., SCOTT R. F. A comparative study of chronic schizophrenics and normal subjects on a work task involving sequential operations. J Ment Sci. 1962 May;108:309–316. doi: 10.1192/bjp.108.454.309. [DOI] [PubMed] [Google Scholar]
  20. WADSWORTH W. V., WELLS B. W., SCOTT R. F. A comparative study of the fatiguability of a group of chronic schizophrenics and a group of hospitalized non-psychotic depressives. J Ment Sci. 1962 May;108:304–308. doi: 10.1192/bjp.108.454.304. [DOI] [PubMed] [Google Scholar]
  21. WEAVER L. A., Jr, BROOKS G. W. THE USE OF PSYCHOMOTOR TESTS IN PREDICTING THE POTENTIAL OF CHRONIC SCHIZOPHRENICS. J Neuropsychiatr. 1964 Feb;5:170–180. [PubMed] [Google Scholar]
  22. WEAVER L. A., Jr, BROOKS G. W. The effects of drug-induced Parkinsonism on the psychomotor performance of chronic schizophrenics. J Nerv Ment Dis. 1961 Aug;133:148–154. doi: 10.1097/00005053-196108000-00011. [DOI] [PubMed] [Google Scholar]
  23. WING J. K. A simple and reliable subclassification of chronic schizophrenia. J Ment Sci. 1961 Sep;107:862–875. doi: 10.1192/bjp.107.450.862. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES